A Korean-style precision medical project was launched, involving 25 hospitals and 19 software companies across the country. The companies plan to develop the AI-based precision medical solution 'Dr. Answer' to be used in the prediction, diagnosis and treatment of eight diseases such as heart disease, breast cancer, colon cancer and dementia.
The Ministry of Science and ICT announced that the ministry would launch the 'AI-based Precision Medical Solution Development' project at the Asan Medical Center in Pungdam-dong, Seoul on April 30 and will invest 35.7 billion won by 2020. Dr. Answer is a service that supports the prediction, diagnosis and treatment of individuals’ diseases by analyzing diagnostic information, medical images, genome information and life patterns. The goal is to develop 21 experience-based AI medical SW programs in relation to the eight diseases. The development of Dr. Answer will be participated in by 19 software companies including Samsung SDS. In addition, 25 medical institutions across the country will join the project, including the so-called 'Big Five' hospitals -- Seoul Asan Hospital (the general project management hospital), Seoul National University Hospital, Severance Hospital, Seoul St. Mary's Hospital and Samsung Seoul Hospital.
Eight major diseases are cerebrovascular diseases, heart diseases, breast cancer, colorectal cancer, prostate cancer, dementia, brain cancer and rare genetic diseases of children.
The project group will develop AI-based software that assists and supports medical staffs such as big data analysis, information retrieval, and condition monitoring. The group will also push forward with the development of integrated medical data visualization software that can be used for diagnosis, treatment, surgery, education and training, psychological treatment and rehabilitation.
The Ministry of Science and ICT is planning to open up a new market for medical SW by linking with the Precision-Hospital Information System (P-HIS), which is currently under development in the cloud system. The gap between regional medical service and medical expenses are expected to be reduced. This year, the group will develop SW on cardiovascular diseases, dementia and rare genetic diseases of children first.